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Impaired surface membrane 
insertion of homo- and 
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chloride channels carrying amino-
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Birgit Begemann1, Toni Becher1, Petra Kilian1, Matthias Grieschat1, Jan-Philipp Machtens4, 
Günther Schmalzing3, Martin Fischer1 & Christoph Fahlke4
Mutations in the muscle chloride channel gene (CLCN1) cause myotonia congenita, an inherited 
condition characterized by muscle stiffness upon sudden forceful movement. We here studied the 
functional consequences of four disease-causing mutations that predict amino acid substitutions 
Q43R, S70L, Y137D and Q160H. Wild-type (WT) and mutant hClC-1 channels were heterologously 
expressed as YFP or CFP fusion protein in HEK293T cells and analyzed by whole-cell patch clamp 
and fluorescence recordings on individual cells. Q43R, Y137D and Q160H, but not S70L reduced 
macroscopic current amplitudes, but left channel gating and unitary current amplitudes unaffected. 
We developed a novel assay combining electrophysiological and fluorescence measurements at the 
single-cell level in order to measure the probability of ion channel surface membrane insertion. With 
the exception of S70L, all tested mutations significantly reduced the relative number of homodimeric 
hClC-1 channels in the surface membrane. The strongest effect was seen for Q43R that reduced the 
surface insertion probability by more than 99% in Q43R homodimeric channels and by 92 ± 3% in 
heterodimeric WT/Q43R channels compared to homodimeric WT channels. The new method offers a 
sensitive approach to investigate mutations that were reported to cause channelopathies, but display 
only minor changes in ion channel function.
Myotonia congenita is an inherited human disease characterized by muscle stiffness, muscle hypertro-
phy, and sustained muscle contraction upon action and percussion1,2. The delayed muscle relaxation is 
due to the occurrence of repetitive electrical discharges of affected fibers, the so-called myotonic runs. 
Hyperexcitability is caused by a greatly diminished sarcolemmal chloride conductance in affected mus-
cle3. Skeletal muscle fibers are unique among excitable tissue in a large resting chloride conductance that 
results in short electrical length constants of the sarcolemma4. This feature is necessary for electrical 
1Institut für Neurophysiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, Hannover, Germany. 
2Hôpital Pitié-Salpêtrière, 47–83 Boulevard de l’Hôpital,Paris, France. 3Abteilung Molekulare Pharmakologie, 
RWTH Aachen University Templergraben 55, Aachen, Germany. 4Institute of Complex Systems-Zelluläre Biophysik 
(ICS-4), Forschungszentrum Jülich, Germany. Correspondence and requests for materials should be addressed to 
C.F. (email: c.fahlke @fz-juelich.de)
Received: 17 June 2015
Accepted: 23 September 2015
Published: 27 October 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:15382 | DOi: 10.1038/srep15382
stability of the muscle fiber since repetitive action potentials result in accumulation of K+ within the 
T-tubules of adult skeletal muscle. In the absence of the shunting sarcolemmal chloride conductance 
T-tubular K+ accumulation depolarizes the sarcolemmal membrane and triggers muscle action potentials 
in the absence of motoneuron activity6.
In recent years, various mutations in the CLCN1 gene have been identified in autosomal dominant 
(Thomsen) and autosomal recessive (Becker) myotonia7,8. Functional consequences on hClC-1 channel 
gating or permeation have been elucidated by heterologous expression of mutant hClC-19–20. In many 
cases, alteration of channel function predicted a significant reduction of the macroscopic chloride con-
ductance that explains muscle hyperexcitability. However, there are also disease-causing mutations that 
leave functional properties of hClC-1 channels unaffected. Channels with unaltered gating and permea-
tion might cause myotonia by impaired surface membrane insertion. However, this parameter has been 
rarely addressed, and so far no experimental approaches are available to study and quantify surface 
membrane insertion capability at the single cell level.
In a systematic screen of all 23 exons of the CLCN1 gene in seven patients with recessive generalized 
myotonia (Becker) we found four missense mutations predicting amino acid exchanges Q43R, S70L, 
Y137D and Q160H. Q43 and S70 are located in the amino-terminus, Y137 in the B helix and Q160 in 
the C helix of hClC-1 chloride channels (Fig. 1a). Various myotonia-associated nonsense mutations that 
Figure 1. Myotonia-associated mutations modify mean current amplitudes in heterologous expression 
system without reducing protein expression levels. (a) Location of the tested mutations in a topology 
model of the chloride channel protein modified from Dutzler et al.5 (b) Representative currents of WT 
and mutant hClC-1 recorded under symmetric chloride conditions. (c) Voltage dependence of mean 
instantaneous current amplitudes (means ± SEM from 6–18 experiments). (d) Relative expression levels of 
WT and mutant hClC-1 channels given from relative fluorescent values (lower panel, means ± SEM from 
5 experiments) and representative fluorescence scan of a SDS-PAGE gel of YFP-tagged WT and mutant 
hClC-1 channels in the total cleared lysate of cells that were transfected with equal amounts of plasmid 
DNA. The expected molecular mass of mYFP-hClC-1 is 136 kDa. In each experiment lysate samples were 
adjusted to equal total protein amounts before loading the gel. (Student’s two-tailed t-test with *p < 0.05 and 
***p < 0.001).
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predict hClC-1 truncation in its amino-terminus are known21–23. However, only one pathogenic missense 
mutation in the hClC-1 amino-terminus – predicting the exchange of threonine by alanine at position 
82 - has been reported24. Q43R and S70L are the most amino-terminal localized disease-causing mis-
sense mutations in the whole CLC gene family. We studied homo- and heterodimeric mutant channels 
in heterologous expression systems and found that all mutations leave channel function unaffected, but 
reduce surface membrane insertion. To compare the severity of the trafficking defects caused by the 
different mutations we developed a novel assay that uses a combination of cellular electrophysiology and 
fluorescence microscopy. This approach permitted accurate quantification of the percentage of homo- 
and heterodimeric channels embedded in the plasma membrane.
Results
Genetic screening of CLCN1. We tested seven patients with typical myotonic symptoms such as 
muscle stiffness, muscle hypertrophy and myalgia that improved during exercise for mutations in CLCN1. 
All tested patients carried different mutations in both alleles (Table 1). The co-existence of two CLCN1 
mutations in affected individuals as well as the occurrence of mutations in clinically unaffected father 
and mother supports a recessive inheritance mode of the disease-causing mutations.
In the index patient of family 1, we identified a novel c.128 A> G p.Gln43Arg (Q43R, exon 1) mis-
sense mutation in one allele, and an already known intronic c.180+ 3 A> T (IVS1+ 3 A> T) mutation in 
the other allele25. Affected members of family 2 exhibit a novel c.209 C> T p.Ser70Leu (S70L, exon 2) 
mutation together with the intronic c.1471+ 1 G> A (IVS13+ 1 G> A, intron 13)26 mutation. A third 
missense mutation located in B helix, c.409 T> G p.Tyr137Asp (Y137D, exon 3)27, was found in a het-
erozygous state in four other myotonia congenita index cases (families 3–6). In each index case it was 
associated with other heterozygous mutations: the recessive c.180+ 3 A> T splice mutation in family 325, 
the recessive missense c.1488 G> T p.Arg496Ser26,28 in family 4, the presumably recessive c.2365-2 A> G 
splice site mutation (intron 19, acceptor site) in family 5, and the missense c.2564 G> A p.Gly855Glu 
(G855E, exon 22) in family 6. Gly855Glu (G855E, exon 22) was also found in compound heterozygous 
state in another patient in our laboratory. We assume that this mutation, which has never been described 
in the literature, is recessive. In the index patient of family 7, sequencing revealed the mutations c.480 
G > C p.Gln160His (Q160H29, exon 4) and c.2680 C> T p.Arg894* (R894X, exon 23)30,31.
The disease-associated mutations Q43R, S70L, Y137D and Q160H predict amino acid substitutions 
within a region of the hClC-1 subunit (Fig. 1a) whose function is insufficiently understood. We decided 
to investigate the functional consequences of these mutations in transfected mammalian cells.
Functional characterization of mutant hClC-1. To obtain a homogenous population of 
 homodimeric channels we transfected 0.5–1.0 μ g pSVL-mYFP-hClC-1 encoding WT or mutant hClC-1 
in HEK293T cells and studied transfected cells through whole-cell patch clamping. Figure  1b shows 
representative whole-cell current recordings from cells expressing WT, S70L, Y137D or Q160H hClC-1. 
For WT as well as for mutant channels, currents increased instantaneously upon voltage steps to nega-
tive potentials followed by a slower decrease of the current amplitude due to voltage-dependent channel 
gating31,32. Current responses to depolarizing voltage steps were time-independent.
When using similar transfection protocols as for WT and the other mutants, we observed currents 
with characteristic hClC-1 properties only in a small number of cells expressing Q43R hClC-1. These cur-
rents had very small peak current amplitudes (at − 155 mV: 0.17 ± 0.04 nA, n = 6), and augmenting the 
amount of transfected DNA did not significantly enhance these currents. We reasoned that the number 
of Q43R hClC-1-YFP in the surface membrane might be increased by further enhancing the expression 
levels of this particular mutant protein. We therefore subcloned the coding region of Q43R hClC-1-YFP 
into pRcCMV, an expression plasmid with stronger promoter and transfected larger DNA amounts (2 μ g) 
than for WT. Under these conditions, we regularly observed small currents that resembled hClC-1 in 
time and voltage dependence (Fig. 1b). Figure 1c gives mean current amplitudes from cells transfected 
with pSVL-mYFP-hClC-1 encoding WT, S70L, Y137D or Q160H hClC-1 or with pRcCMV-mYFP-Q43R 
hClC-1. Whereas S70L and WT currents were comparable, Y137D and Q160H reduced macroscopic 
current amplitudes by about 50%. Despite using a stronger promoter for heterologous expression cells 
transfected with pRcCMV-mYFP-Q43R hClC-1 exhibited by far the smallest current amplitudes.
To test whether the different macroscopic current amplitudes in cells expressing WT or mutant 
hClC-1 are due to impaired mutant protein biogenesis, we transfected equal amounts of WT and mutant 
pSVL-mYFP-hClC-1 in HEK293T cells and compared expression levels by SDS PAGE (Fig. 1d). Scanning 
the wet polyacrylamide gels with a fluorescence scanner revealed a single protein band with a molecular 
weight corresponding to values expected for channel fusion protein. Additional fluorescent protein frag-
ments were absent demonstrating that proteolytic cleavage is negligible and that the number of channel 
proteins is proportional to YFP fluorescence amplitudes. Quantitative analysis of fluorescence intensities 
demonstrates slight, but significant decreases in expression levels of S70L, Y137D or Q160H hClC-1-YFP, 
but greatly increased levels for Q43R hClC-1-YFP. The reduction in macroscopic current amplitudes in 
cells expressing mutant channels is therefore not due to impaired protein biosynthesis.
Mutations can reduce macroscopic chloride conductances by modification of the unitary current 
amplitude or the absolute open probability. We employed non-stationary noise analysis to determine these 
two values. Supplementary Fig. S1 illustrates a representative analysis for WT hClC-1 (Supplementary 
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Family Nr
Family 
member Sex Age Symptomatic and/or anamnestic data Electrophysiology data Other data Molecular data
366 index case F 41 muscle stiffness that is alleviated by exercise nd
c.128 A > G p.Gln43Arg (Q43R, exon 1) 
c.180 + 3 A > T (intron 1)
father m — asymptomatic nd c.128 A > G p.Gln43Arg (Q43R, exon 1)
mother f — asymptomatic nd c.180 + 3 A > T (intron 1)
427 index case M 22
age at onset 15, severe muscle stiffness 
with moderate myalgia upon movement 
onset, ameliorated during continuation 
of effort, cold-insensitive
myotonic bursts, abundant (left 
short abductor pollicis, left 
biceps) or rare (left quadriceps), 
repeated short effort test: type III 
response
[CK] 424 
UI absence 
of DMPK 
expansion
c.209 C > T p.Ser70Leu (S70L, exon 2) 
c.1471 + 1 G > A (intron 13)
father m — asymptomatic nd c.209 C > T p.Ser70Leu  (exon 2)
mother f — asymptomatic nd c.1471 + 1 G > A (intron 13)
234 index case M 29 muscle stiffness that is alleviated by exercise nd
c.409 T > G P.Tyr137Asp (Y137D, exon 3) 
c.180 + 3 A > T (intron 1)
father m — asymptomatic nd nd
mother f — asymptomatic nd nd
457 index case M 37 myotonia with marked amelioration during exercise nd
c.409 T > G P.Tyr137Asp (Y137D, exon 3) 
c.1488 G > T p.Arg496Ser (R496S, exon 14)
affected sibling M — symptoms identical to index case nd nd
father m — reported as affected on genetic tree, however no precise data available nd
c.409 T > G P.Tyr137Asp (Y137D, exon 3) 
No other point mutation (all CLCN1 and 
SCN4A exonic regions sequenced)
mother f — asymptomatic nd nd
1565 index case F 32 myotonia myotonic bursts
absence 
of DMPK 
expansion
c.409 T > G P.Tyr137Asp (Y137D, exon 3) 
c.2365—2 A > G (intron 19)
father m — nd nd nd
mother f — nd nd nd
1581 index case M 35
age at onset 18, stiffness and myalgia 
the morning at awakening with 
correction by warm—up, muscle 
hypertrophy
myotonic bursts, abundant
[CK] 
400–530 
UI
c.409 T > G P.Tyr137Asp (Y137D, exon 3) 
c.2564 G > A p.Gly855Glu (G855E, exon 
22)
father m — asymptomatic nd nd
mother f — asymptomatic nd nd
1541 index case M 57 feeling of muscle stiffness needing a warm-up, muscle hypertrophy myotonic bursts
c.480 G > C p.Gln160His (Q160H, exon 4) 
c.2680 C > T p.Arg894* (R894X, exon 23)
father m — nd nd nd
mother f — asymptomatic nd nd
Table 1.  Clinical and molecular data of the investigated patients.
information). Variance values were plotted versus mean current amplitudes (Supplementary informa-
tion, Supplementary Fig. S1b), and a quadratic equation was fitted to the data, providing the number 
of channels in the cell surface membrane and the unitary current amplitude (N = 18,000; i = 0.28 pA at 
− 155 mV)33. Fig. S1c and d (Supplementary information) display the same type of analysis for mutant 
Q43R channels (N = 17385; i = 0.32 pA at − 155 mV). We observed unaltered single-channel current 
amplitudes for Q43R as well as for all the other tested mutations (Fig. 2a). Moreover, we could not detect 
significant alterations of the maximum absolute open probability (Fig.  2b). We next determined the 
voltage dependence of relative open probabilities for WT and mutant channels by plotting instantaneous 
current amplitudes at a voltage step to − 125 mV versus the preceding potential (Fig. 2d). Since WT and 
mutant hClC-1 display a maximum absolute open probability of 1 at positive potentials and since none 
of the mutants causes significant alterations of this maximum value, such relative open probabilities are 
in all cases identical with absolute open probabilities31. For all mutant channels we observed unaltered 
voltage dependences of open probabilities.
hClC-1 channels are known to exhibit two different gating processes. Fast gating opens and closes 
individual protopores, while slow cooperative gating steps act on both protopores together13. Insertion of 
a short pulse to + 180 mV into the pulse protocol prior to the test step to − 125 mV (Fig. 2c) fully acti-
vates the fast gate and permits acquisition of the relative open probability of the slow gate31,34 (Fig. 2e). 
Assuming that fast and slow gating occur independently of each other, open probabilities of the fast 
gate were calculated by dividing the channel open probability by the relative slow gate activation curve 
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(Fig. 2f). S70L and Q160H did not modify the slow gate, whereas Q43R and Y137D increased the mini-
mum open probability of the slow gate. These slight changes left the total open probability of the channels 
virtually unaffected since open probabilities of the fast gate are very low at negative potentials.
We conclude that none of the studied disease-causing mutations leads to changes in hClC-1 functions 
that could account for the observed reduction in whole-cell current amplitudes of Q43R, Y137D and 
Q160H and for the reduced resting chloride conductance in affected muscle.
Subcellular distribution of WT and mutant hClC-1. We next investigated the subcellular dis-
tribution of WT and mutant hClC-1 channels using confocal microscopy. For these experiments we 
used MDCK II cells, an established model to investigate trafficking of endogenous or heterologously 
expressed proteins35–37. We expressed fluorescent mYFP-tagged fusion proteins of hClC-1 and examined 
transfected cells by confocal imaging (Supplementary information, Supplementary Fig. S2). In agree-
ment with earlier studies38, WT hClC-1-YFP does not exclusively insert into the surface membrane, 
but causes additional staining of intracellular compartments. This contrasts the predominant sarcolem-
mal/T-tubular localization of hClC-1 in native tissue39,40 and is most likely caused by overexpression of 
hClC-1 fusion proteins (our own unpublished observations). S70L hClC-1-YFP exhibited a comparable 
subcellular distribution as WT hClC-1-YFP (Supplementary information, Fig. S2). The remaining muta-
tions resulted in alterations of the subcellular distribution of mYFP-hClC-1 fusion proteins. Q160H and 
Figure 2. Functional properties of homodimeric mutant channels. (a,b) Mean single-channel current 
amplitudes at − 155 mV (a) and absolute open probabilities at + 55 mV (b) as obtained from non-stationary 
noise analysis for mutant hClC-1 (means ± SEM from 4–5 experiments). Solid lines represent WT unitary 
current amplitude and absolute open probability. (c) Representative tail currents from experiment to 
determine the voltage dependence of the slow common gate. (d) Voltage dependence of the probability of 
WT or mutant hClC-1 channels to be open. (e,f) Activation curves of the slow (e) and the fast (f) gate of 
WT or mutant hClC-1 channels (means ± SEM from 7–14 experiments).
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Y137D increased intracellular staining, with prominent appearance of mutant hClC-1-mYFP in intracel-
lular compartment. We did not attempt to clarify into which cell compartments mutant fusion proteins 
are mis-targeted. For Q43R hClC-1-YFP, surface staining was absent, and almost all protein was present 
in intracellular compartments. For WT as well as for mutant fusion proteins, no nuclear staining was 
observed (Supplementary information, Fig. S2). This supports the notion that fusion proteins are fully 
translated and proteolytic cleavage is negligible41. These changes in subcellular distribution provide an 
explanation for the reduced whole-cell current amplitudes, but do not allow quantitative assessment of 
altered hClC-1 surface insertion probabilities.
Quantification of relative membrane insertion probabilities by combined fluorescence and 
current recordings. We developed a novel assay that combines fluorescence and current recordings 
to quantify changes in surface membrane insertion capability of hClC-1 by disease-causing mutations. 
Since unitary current amplitudes and absolute open probabilities are identical for WT and mutant 
hClC-1 (Fig.  2), macroscopic current amplitudes are proportional to the number of channels in the 
surface membrane of transfected HEK293T cells. To measure the total number of hClC-1 subunits – in 
intracellular organelles and the surface membrane – we expressed WT and mutant hClC-1 as mYFP 
fusion protein and measured the whole-cell fluorescence42. In these experiments we adjusted the trans-
fected plasmid quantities so that macroscopic current amplitudes are in a comparable range (0.2–0.5 μ g 
pSVL-mYFP-WT hClC-1, 0.5 μ g pSVL-mYFP-hClC-1 encoding S70L, Y137Q, or Q160H hClC-1-YFP, 
or 2 μ g pRcCMV-mYFP-Q43R hClC-1). Figure  3a,b show representative recordings from a HEK293T 
cell expressing WT hClC-1-YFP and another cell expressing Q43R hClC-1-YFP. The upper traces display 
current responses to a series of voltage steps consisting of an activating prepulse to + 75 mV and test steps 
to various voltages between − 175 mV and + 85 mV. The lower traces depict the whole-cell fluorescence 
that increases upon opening of a shutter for optical excitation. Cells expressing WT hClC-1-YFP produce 
large current amplitudes and low whole-cell fluorescence levels, indicating a high fraction of channels 
inserted into the surface membrane. The use of a stronger promoter resulted in high fluorescences, but 
only small macroscopic current amplitudes in pRcCMV-mYFP-Q43R hClC-1-transfected cells (Fig. 3b).
Figure 3c,d display the correlation between current amplitude and whole-cell fluorescence for several 
cells expressing WT or mutant hClC-1-YFP. For all tested mutants we observed a linear relationship 
between these two variables over the tested range of fluorescence levels, indicating that channel expres-
sion did not saturate intracellular transport processes under our experimental conditions. The slopes 
of the linear regression lines (I/F = whole-cell current/whole-cell fluorescence) are proportional to the 
probability of channels being inserted into the surface membrane (Pins).
hClC-1 are double-barrelled channels which are assembled from two subunits13.
= ( )I ni P PSince 2 1open ins
= ( )F nfand 2 2
/ = = ⋅
( )
I F P
iP
f
P const
3ins
open
ins
n is the number of all channels expressed in the cell, either in intracellular compartments or in the sur-
face membrane, i the unitary current amplitude of an individual protopore, Popen the open probability and 
f the single-subunit fluorescence. In our analysis we assume that f is the same for all tested constructs. 
Since the YFP moiety was added to the unstructured amino-terminus of WT and mutant hClC-1, the 
fluorescent protein will fold independently of hClC-1, and mutations in hClC-1 are not expected to affect 
YFP maturation or fluorescence lifetimes or quantum yield43.
Comparison of regression lines provided different slopes for WT and mutant channels (Fig. 3c,e). The 
most pronounced effect was observed for Q43R, with a 300fold reduction of the relative insertion prob-
ability as compared to WT hClC-1 (Fig. 3d,f). No significant difference was observed for S70L (Fig. 3e). 
We conclude that Q43R, Y137D and Q160H impair surface membrane insertion of hClC-1.
Q43R also reduces insertion probability of heterodimeric channels. ClC-1 channels are 
dimers44, and heterodimers are thus expected to represent a major fraction of channels in heterozy-
gous patients. To test whether the disease-associated mutants affect also intracellular trafficking of het-
erodimers we focused on Q43R, the mutation with most pronounced effects on trafficking. We initially 
co-expressed WT and Q43R mutant channels as YFP and CFP fusion proteins, respectively, in MDCK 
II cells and studied the subcellular distribution of the fusion proteins by confocal imaging (Fig.  4a,b). 
In such cells, a large fraction of WT hClC-1-YFP fusion proteins is intracellularly retained co-localizing 
with Q43R hClC-1-CFP, suggesting that mutant subunits impair surface membrane insertion of WT 
hClC-1. However, since expression of WT hClC-1 alone also results in significant staining of intracellular 
compartments, this effect is difficult to quantify.
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We next constructed concatameric WT-Q43R as well as Q43R-WT hClC-1 channels as mYFP fusion 
proteins and studied the correlation of whole-cell current and fluorescence for pure expression of het-
erodimers (Fig.  4c). Since concatamers contained only one fluorescent protein per protein dimer we 
doubled the measured fluorescence values to permit comparison with homodimeric fusion proteins. 
Both concatamers exhibit dramatically reduced surface insertion probabilities (Fig. 4c,d), however, they 
differed in the degree of insertion reduction. Whereas WT-Q43R reduced surface insertion to 2% ± 1% 
of WT, we observed a higher value for Q43R-WT that measured about 8% ± 1% of homodimeric WT 
hClC-1.
We next co-transfected WT and mutant Q43R hClC-1 DNA (0.5 μ g pSVL-mYFP-WT hClC-1 and 
2 μ g pRcCMV-mYFP/CFP-Q43R hClC-1) and analyzed the surface membrane insertion probabili-
ties of heterodimeric channels with a modified approach of combined fluorescence/electrophysiology. 
Increasing CFP-fractions upon co-expression of Q43R subunits will decrease the fraction of WT subunits 
(CFP-fraction + YFP-fraction = 1) and also the percentage of WT homodimers by the formation of het-
erodimers. Figure 4e depicts the quotient of current by the YFP fluorescence (I/FYFP) versus the fraction 
of CFP-tagged Q43R hClC-1 subunits for 25 cells. These data demonstrate that a higher percentage of 
Figure 3. Simultaneous investigation of channel expression and surface membrane insertion. (a,b) 
Representative recording of the fluorescence (gray lines) and current (black lines) of cells expressing WT 
(a) or Q43R hClC-1 channels (b). (c,d) Correlation between instantaneous current amplitudes at − 135 mV 
and whole-cell fluorescences for WT and mutant hClC-1. Lines represent linear regressions (regression 
coefficients are: 0.47 (WT) 0.77 (S70L); 0.32 (Y137D); 0.57 (Q160H); 0.35 (Q43R)). (e,f) Slopes of linear 
regression lines reveal relative membrane insertion rates for WT and mutant hClC-1 (means ± SEM from 
13–23 experiments). Membrane insertion is significantly reduced by Q43R, Y137D and Q160H, but not by 
S70L (***Student’s two-tailed t-test with p < 0.001).
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CFP-Q43R hClC-1 subunits are associated with reduced I/FYFP, indicating lower insertion probabilities 
of heterodimeric channels than of homodimeric WT channels.
Under the assumption of a binomial distribution of WT and mutant homodimeric and WT-mutant 
heterodimeric channels, anion currents of cells co-expressing YFP-tagged WT and CFP-tagged Q43R 
subunits equal to
( )= + + ( ), / , / , /I ni P a P ab P b P2 2 4open ins YFP YFP ins YFP CFP ins CFP CFP2 2
with n being the total number of channels, and a and b the fraction of WT hClC-1-YFP (a) and Q43R 
hClC-1-CFP (b) subunits. Pins gives the membrane insertion probability, i the unitary current amplitude 
per protopore and Popen the absolute open probability. Using a relative insertion probability of 1 for 
homodimeric WT and of 0 for homodimeric mutant channels the equation simplifies to
( )= + ( ), /I ni P a ab P2 2 5open ins YFP CFP2
The whole-cell YFP fluorescence (FYFP) depends on the number of WT hClC-1-YFP subunits (2n for 
n channels), the fraction of YFP (a) and the fluorescence amplitude of a single YFP (f)
= ( )F 2naf 6YFP
so that
/ = + = / ( ), /I F aK 2bKP with K iP f 7YFP ins YFP CFP open
Since a + b = 1:
( )/ = − + ( ), /I F 2P 1 Kb K 8YFP ins YFP CFP
Fitting equation (8) to the plot of I/FYFP versus the CFP-fraction (b) allows determination of the insertion 
probability of heterodimers. We determined the fit reliability and the regression error using bootstrap 
sampling (using 50.000 bootstrap samples with replacement as described in45). The thus obtained fit 
parameters indicate that heterodimeric channels assembled from one WT and one Q43R hClC-1  subunit 
exhibit a significantly decreased surface insertion probability that equals 8 ± 3% of WT homodimers 
(Fig. 4f).
Q43R does not interfere with homo- or heterodimerization. To test whether WT subunits asso-
ciate equally well with WT and with Q43R subunits, we expressed hClC-1 proteins either as His-hClC-
1-YFP or as His-hClC-1-StrepII in Xenopus oocytes and purified them by metal affinity or StrepTactin 
chromatography. Cell surface-specific labelling of hClC-1 using a membrane-impermeant Cy5-NHS 
ester revealed greatly reduced incorporation of Q43R hClC-1 also into the oocyte plasma membrane 
(Fig.  5a, upper panel, lanes 1 and 2). This result is not attributable to a weak expression, as the [35S]
methionine-labeled forms of the WT and Q43R hClC-1 could be purified in similar amounts from the 
oocytes (Fig.  5a, lower panel). Both WT and Q43R hClC-1 migrated at approximately 114 kDa in the 
SDS-PAGE gel, close to the calculated 110 kDa of the hClC-1 apoprotein.
We next compared the assembly efficacy of Q43R hClC-1 by BN-PAGE under conditions known to 
preserve the homodimeric state of hClC-146. After purification WT and Q43R His-hClC-1-YFP migrated 
to the same position in the BN-PAGE gel in their non-denatured state, as detected by scanning the 
fused YFP fluorescence or the 35S radioactivity originating from metabolic [35S] methionine incorpora-
tion (Fig. 5b, lanes 1 and 3, upper and lower panels). Denaturation with 0.1% SDS resulted in complete 
disassembly of WT and Q43R hClC-1 homodimers (Fig. 5b, lanes 2 and 4). To assess whether the WT 
and Q43R hClC-1 assemble equally well with each other, we took advantage of the larger mass and the 
YFP fluorescence of the hClC-1-YFP fusion proteins as compared to His-hClC-1-StrepII. Co-expression 
of WT His-hClC-1-StrepII with WT His-ClC-1-YFP resulted in the appearance of two distinct YFP 
fluorescent bands in the BN-PAGE, the hClC-l-YFP homodimer and the 29 kDa smaller hClC-1-YFP/
hClC-1 heterodimer (Fig.  5b, lane 5, upper panel). Exactly the same pattern of bands was seen upon 
co-expression of the WT His-ClC-1 with Q43R His-hClC-1-YFP (Fig.  5b, lane 7, upper panel). These 
data indicate that the WT hClC-1 assembles equally well with the WT and Q43R hClC-1-YFP. Upon 
denaturation with SDS, only one faster migrating band could be seen, the His-hClC-1-YFP protomer 
(Fig.  5b, lanes 6 and 8, upper panel). The 35S-phosphorimager scan of the BN-PAGE gel additionally 
made visible the YFP-less proteins, the WT and Q43R hClC-1 protomers and the WT and Q43R hClC-1 
homodimers (Fig.  5b, lanes 5–8, lower panel). We conclude that Q43R does not affect the assembly 
capacity of the hClC-1.
Discussion
Disease-causing mutations often result in significant alterations of ion channel gating and permeation. 
However, there are also many examples that leave these channel properties unaffected and merely result 
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in changes of macroscopic current amplitudes. In these cases it is often assumed that the mutation affects 
subcellular trafficking of mutant ion channels. We here report a novel approach that permits quantifica-
tion of surface membrane insertion of mutant muscle chloride channels at the single cell level.
Figure 4. Heterodimeric channels assembled from WT and Q43R hClC-1 exhibit a reduced surface 
membrane insertion probability. (a,b) Confocal image (a) and corresponding profile intensities (b) for 
MDCK II cells co-expressing mYFP tagged WT and CFP-tagged Q43R hClC-1. Cells were co-transfected 
with 0.2 μ g pSVL-mYFP-WT hClC-1 and 0.5 μ g pSVL-mCFP-Q43R hClC-1. (c) Correlation between 
instantaneous current amplitude at − 135 mV and whole-cell fluorescence for cells expressing WT or Q43R 
homodimers, or WT-Q43R or Q43R-WT heterodimeric concatamers. (d) Relative membrane insertion 
rates of homo- and heterodimers (means ± SEM from 11–23 experiments) (Student’s two-tailed t-test with 
*p < 0.05 and ***p < 0.001). (e) Plot of the current by YFP fluorescence ratio versus the CFP fluorescence 
from 21 cells co-expressing WT hClC-1-mYFP and Q43R hClC-1-CFP. I/FYFP was normalized to values 
obtained for WT hClC-1-YFP in absence of Q43R hClC-1-CFP (fraction of CFP = 0). The y-axis intercept is 
determined by the mean current by fluorescence ratio from 29 cells that exclusively express WT hClC-1-YFP 
(shown as mean ± SEM in red). (f) Distribution of estimated surface membrane insertion probabilities from 
50,000 bootstrap samples of the original data. Histograms have been normalized such that the integral over 
the range is 1 and fitted with a Gaussian function (μ = 0.081, σ = 0.034).
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We focused on two novel (Q43R and S70L) and two already known (Y137D and Q160H)27,29 
myotonia-associated CLCN1 mutations. These CLCN1 mutations were found in seven patients who 
exhibited typical myotonic symptoms such as muscle stiffness that disappeared upon muscle activity 
(warm-up phenomenon), muscle hypertrophy and myalgias in some of the cases and typical myotonic 
bursts in EMG recordings (Table  1). In all cases, father and mother were asymptomatic, in agreement 
with a recessive inheritance mode. All patients were compound heterozygous, with one missense muta-
tion predicting amino acid exchanges in the amino-terminus. Most myotonia-causing mutations are very 
rare, and compound heterozygosity is therefore a frequent finding in patients with recessive generalized 
myotonia congenita12,14,17,25,26,29,33. In these patients, three types of hClC-1 are expressed, homodimeric 
hClC-1 carrying one of the two mutations as well as heterodimeric channels assembled of one subunit 
with one mutation and a second subunit carrying the other mutation. The asymptomatic parents are 
 heterozygous for each of the two mutations, and will thus express homodimeric mutant and WT chan-
nels together with heterodimeric channels consisting of one mutant and one WT subunit.
Q43R and S70L predict amino acid exchanges amino-terminal to the A helix, Y137D in the B helix 
and Q160H in the C helix of the human muscle chloride channel hClC-1 (Fig. 1a). For all tested muta-
tions, we observed identical unitary current amplitudes and absolute open probabilities as well as vir-
tually unchanged current kinetics (Fig. 2, Supplementary Fig. S1). However, three of the four mutations 
reduced macroscopic current amplitudes (Fig. 1). Since the function of mutant channels was unaltered 
the current reduction must have been exclusively caused by a decreased number of channels in the 
surface membrane. To quantify disease-associated impairment of surface membrane insertion, we simul-
taneously measured anion currents and fluorescences of YFP-tagged channels in individual cells. We 
reasoned that measuring current amplitudes is the most accurate method to determine the number of 
anion channels in the surface membrane. Expression of fusion proteins of hClC-1 channels and fluores-
cent proteins permits determination of the number of channels in intracellular compartments as well as 
in the surface membrane using fluorescence measurements42,43. The ratio of macroscopic current ampli-
tude by whole-cell fluorescence provides a value that is proportional to the membrane surface insertion 
probability and permits comparison of WT and mutant channels in their ability to reach the plasma 
membrane in a single cell assay (Fig. 3).
Figure 5. hClC-1 oligomerization is not impaired by Q43R. (a) SDS-PAGE gel (4–10% gradient) of WT 
and Q43R hClC-1 after expression in Xenopus oocytes and purification via StrepTactin chromatography. 
Proteins were visualized by scanning of plasma membrane-bound fluorescence (upper panel) or 35S-labeled 
total protein (lower panel). (b) Oligomeric state of WT and mutant hClC-1 channels. Indicated hClC-1 
proteins were purified via metal affinity chromatography, resolved by BN-PAGE (4–12% gradient) and 
visualized by scanning of YFP fluorescence (upper panel) and 35S-labeled total protein (lower panel). The 
protein migration is shown both under native conditions and following partial denaturation after a 1-h 
incubation with 0.1% SDS at 37 °C, as indicated. The gray ovals without and with yellow balls schematically 
illustrate YFP-less and YFP-fused hClC-1, respectively, to indicate the native dimeric and denatured 
protomeric states of the corresponding protein bands. The data shown represent samples run on the same 
SDS-PAGE gel or BN-PAGE gel; irrelevant lanes were cropped from the figure as indicated by vertical lines. 
The respective source images of the individual gels are shown in Supplemental Fig. S3a and b.
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A frequently used method to estimate the protein fraction in the surface membrane is surface 
 biotinylation20. It relies on covalent reaction of biotin with the channel protein and successive non-covalent 
binding to neutravidin beads. Both reactions have incomplete efficiency and thus underestimate the 
number of surface membrane inserted as well as the number of intracellular hClC-1. Moreover, bio-
chemical approaches require large numbers of individual cells and are thus incapable to detect differences 
between individual cells. Thus, surface biotinylation cannot account for heterogeneous cell populations 
that are caused by different protein expression levels. Subcellular channel distribution might be altered 
upon protein overexpression in heterologous expression systems. Our approach compares surface mem-
brane insertion of multiple cells with different expression levels and thus provides direct information 
about such aberrant localization in overexpressing cells. All these features make our single cell assay 
more accurate and more sensitive than surface membrane biotinylation.
The surface membrane insertion probability was three- to fourfold reduced by Y137D and Q160H, 
and Q43R decreased the current by fluorescence ratio by almost 300. This dramatic reduction required 
expression of much higher numbers of Q43R fusion proteins to obtain measurable current amplitudes. 
However, even at these increased protein levels, we observed a linear relationship between expression 
levels and membrane currents, indicating that none of the distinct trafficking steps was saturated. These 
findings also argue against toxic effects of the high Q43R hClC-1-YFP protein expression levels that may 
additionally disturb targeting of the channel.
All mutations under study exclusively modify intracellular trafficking of ClC-1, and one might thus 
expect a correlation between current amplitude reduction in heterologous expression systems and the 
severity of myotonic symptoms. However, patients with Q43R did not exhibit more pronounced symp-
toms than patients carrying other mutations. This is in agreement with earlier reports that did not find 
any correlation between alterations of hClC-1 channel function in heterologous expression systems and 
myotonic symptoms31,47.
For S70L, we observed macroscopic current amplitudes and current/fluorescence slopes that are com-
parable to WT hClC-1 and were therefore unable to identify any change in function that might account 
for sarcolemmal hyperexcitability in the affected patient. However, several lines of evidences support the 
notion that S70L is a recessive mutation, rather than a benign polymorphism. The mutation was never 
found in more than 700 control samples sequenced in our laboratory. Affected members of family 2 are 
compound heterozygous carrying the c. 1471+ 1 G > A (IVS13 + 1 G > A, intron 13) in the other allele. 
This intronic mutation was reported before as recessive mutation in another compound heterozygous 
patient26. Thus, we have to assume that S70L modifies hClC-1 properties that cannot be studied in a 
heterologous expression system. One might speculate that S70L affects hClC-1 insertion into muscle spe-
cific membrane compartments. At present, it is not clear whether hClC-1 is exclusively expressed in the 
sarcolemma40, or uniformly distributed over sarcolemma and t-tubular invaginations39. It appears possi-
ble that S70L might either induce or prevent insertion into the t-tubulus and thus modify sarcolemmal 
excitability48. At present, we are unable to test for such changes in channel trafficking in our experimental 
system. Alternatively, S70L might affect association with muscle-specific proteins or regulatory pathways 
that exist in skeletal muscle, but not in transfected HEK293T cells.
Mutations in CLCN1 can lead to autosomal dominant or recessive myotonia congenita. In heterozy-
gous patients a large fraction of hClC-1 channels consist of one WT and one mutant subunit, and the 
properties of such heterodimeric channels thus define the inheritance mode of myotonia caused by a 
given mutation. All patients of our study are heterozygous with two distinct CLCN1 mutations on each 
allele, whereas relatives with only one mutation do not exhibit symptoms of myotonia congenita. We 
determined the surface membrane insertion of heterodimeric channels consisting of one WT and one 
Q43R subunit using two different methods. We first analyzed concatenated WT-Q43R dimers linked to 
a mYFP moiety. We constructed expression plasmids for both arrangements of the two coding regions, 
and these two constructs differed in apparent surface membrane insertion capability. Since concatenation 
might affect intracellular trafficking we determined surface membrane insertion of heterodimers that 
formed spontaneously in cells co-expressing WT and Q43R hClC-1. This analysis provided a reduc-
tion to 8% in surface insertion probability of heterodimeric channels. This value is closely similar to 
the results obtained for Q43R-WT, but not for WT-Q43R concatenated channels. Covalent linkage of 
two ClC-1 subunits potentially affects intracellular trafficking, possibly because some flexibility of the 
amino-terminus is necessary for normal intracellular trafficking.
The asymptomatic father of the index patient in family 1 carries the Q43R mutation only in one 
CLCN1 allele and is thus expected to co-express WT and Q43R hClC-1 (Table 1). Our results on func-
tion, assembly and trafficking of hetero- and homodimeric Q43R hClC-1 channels predict - assuming 
equal expression of mutant and WT hClC-1 - a reduction of the sarcolemmal chloride conductance to 
about 25% in such heterozygous patients. This drastic reduction is expected to result in sarcolemmal 
hyperexcitability10,12,49,50 and is therefore in disagreement with the apparently recessive inheritance of this 
particular mutation. A possible explanation for recessive inheritance might be that the number of Q43R 
hClC-1 subunits is much lower than of WT subunits, either by decreased Q43R or increased WT expres-
sion51. In both cases, the percentage of heterodimeric channels would be lower than the value (50%) that 
is predicted for equal expression of WT and mutant subunits. Alternatively, myotonic symptoms might 
be modified by additional factors, some of which have already been identified52. The clinical symptoms 
of myotonia congenita are known to exhibit significant heterogeneity and variable expressivity17,47. One 
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might thus imagine that the heterozygous father is not completely asymptomatic, but rather exhibit very 
mild symptoms that precluded diagnosis of myotonia congenita. Lastly, we cannot exclude that cultured 
cells and adult skeletal muscle might subtly differ in intracellular trafficking of homo- or heterodimeric 
channels.
So far, no functional roles have been assigned to within the amino-terminus or helices B and C 
of CLC proteins. Since all mutations reduce surface membrane insertion, one may conclude that the 
hClC-1 amino-terminus regulates intracellular trafficking, in agreement with recent findings on the role 
of amino-terminal retention signals in ClC-353,54. Q43R causes the most pronounced trafficking effect in 
homodimeric mutant channels, and experiments with heterodimeric channels indicate that one mutant 
amino terminus is sufficient to retain hClC-1 channels in intracellular compartment.
In summary, we evaluated the functional consequences of four myotonia-associated CLCN1 muta-
tions that predict single amino acid substitutions in the amino-terminus of hClC-1. We found that none 
of these mutations affected ion permeation and gating properties of muscle chloride channels. However, 
three out of the four tested mutations impair surface membrane insertion of affected channels to variable 
extents. Knowledge about all functional alterations of hClC-1 channels will advance our understanding 
of myotonia congenita and is an important step towards rational therapeutic strategies.
Methods
Clinical data. The seven individuals included in this study were selected from patients who were 
referred to Dr. Sternberg’s laboratory in Hôpital Pitié-Salpêtrière for genetic testing after seeking medical 
advice for muscle stiffness and additional myotonic symptoms. The diagnosis of myotonia was based on 
clinical examination, with electromyography performed in four patients. Additional tests for increased 
creatine kinase activity or Steinert’s dystrophia myotonica protein kinase (DMPK) were performed. 
Clinical, electrophysiological and genetic data of the patients are summarized in Table 1. Family history 
was taken in patient interviews or from known case histories of parents and other relatives.
Molecular genetic analysis. Mutation search in CLCN1 and genetic diagnosis were performed 
according to and approved by French genetic diagnosis laws and according to the Declaration of Helsinki. 
An informed consent was given by each patient and recorded according to French law. The collection 
of patients‘ samples was declared and approved under number 646 by the Paris University hospitals. 
The diagnostic database was declared and approved under number 1412729 by the informatic databases 
French authority. Blood samples were taken after informed consent according to the French law and sent 
for genetic diagnosis of non-dystrophic myotonia. Genomic DNA was extracted from peripheral blood 
lymphocytes. The whole coding region of the CLCN1 was amplified from genomic DNA by PCR, using 
23 primer pairs (available upon request)55. Both forward and reverse sequence reactions were performed 
with the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, 
CA). The sequence products were run on an ABI 3730 automated sequencer (Applied Biosystems), and 
data were analyzed with the Seqscape 2.1 software (Applied Biosystems).
The molecular genetics diagnosis for all patients was performed according to French law, after patients 
were informed about the nature and diagnostic aim of genetic tests and gave their consent to it.
Expression of WT and mutant hClC-1 channels. The QuikChange site-directed mutagenesis 
kit (Stratagene, La Jolla, CA) was used to introduce point mutations into the plasmid pSVL-mYFP/
CFP-hClC-1 containing the full length WT hClC-1 cDNA31 order of appearance with monomeric  YFP 
or  monomeric  CFP covalently linked to the amino-terminus. To boost expression levels we subcloned 
mYFP-Q43R hClC-1 into the pRcCMV vector, and all electrophysiological (Figs 1 and 2) and combined 
fluorescence/electrophysiology data (Figs 3 and 4) provided in this manuscript were generated with cells 
transfected with pRcCMV-mYFP/CFP-Q43R hClC-1. In all cases, homodimeric channels were expressed 
by transfecting monomeric expression plasmids into HEK293T cells. To express a homogenous popu-
lation of heterodimeric channels we constructed and transfected concatameric plasmids as described 
previously44,56. If not noted otherwise, mutant and WT hClC-1 channels were transiently expressed in 
HEK293T cells and examined typically two days after transfection of 0.2–2 μ g cDNA with the calcium 
phosphate precipitation method33.
Our experimental approach required the use of fluorescent ClC-1 fusion proteins, and we decided 
to attach the mYFP moiety to the amino-terminus38. The resulting mYFP-hClC-1 has been intensely 
studied in the past, without any discernable differences in ion conduction, gating or regulation as com-
pared to untagged hClC-1 channels. However, since sequence alterations in the amino-terminus have 
been reported to affect the subcellular localization of CLC channels and transporters53,57, this maneuver 
might affect intracellular trafficking of WT and mutant hClC-1. Identical whole-cell current amplitudes 
of HEK293T cells expressing hClC-1 (peak current amplitude at −135 mV: − 7.55 ± 1.0 nA, n = 18 ) or 
mYFP-hClC-1 (peak current amplitude at − 135 mV: − 7.66 ± 0.79 nA, n = 27) indicate that linkage of 
mYFP to the hClC-1 amino-terminus does not cause major alterations of trafficking.
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Electrophysiology. Standard whole-cell patch clamp recordings were performed using an Axopatch 
200B amplifier (Molecular Devices, Sunnyvale, CA USA). Pipettes were pulled from borosilicate glass 
and had resistances of 1.2–2.2 MΩ . More than 80% of the series resistance was compensated by an 
analog procedure, and the calculated voltage error due to series resistance was always < 5 mV. Currents 
were filtered with an internal 4-pole Bessel filter with 1 kHz (-3dB) and digitized with sampling rates 
of 10–20 kHz using a Digidata AD/DA converter (Molecular Devices, Sunnyvale, CA USA). Cells were 
clamped to 0 mV for at least 2 s between two subsequent test sweeps. The standard internal solution 
contained (in mM): 120 NaCl, 2 MgCl2, 5 EGTA, 10 HEPES, pH 7.4; and the extracellular solution (in 
mM): 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 5 HEPES, pH 7.4. For kinetic analyses, only current amplitudes 
below 10 nA were used, whereas for the determination of peak amplitudes cells with current amplitudes 
larger than 18 nA were omitted.
Data were analyzed by a combination of Clampfit (Molecular Devices, Sunnyvale, CA USA) and 
SigmaPlot (Systat Software Inc., San Jose, CA, USA) programs. Instantaneous current amplitudes were 
measured immediately after capacitive current relaxation (< 500 μ s after the voltage step). To obtain 
the relative probabilities of the channel to be open instantaneous current amplitudes after stepping to 
–125 mV were plotted versus the voltage of a preceding 300 ms pulse and normalized to the maximum 
tail current amplitude. The relative open probability of the slow gate was determined by measuring 
normalized tail current amplitudes after 300 ms prepulses to various potentials and a short fixed pulse 
of 0.5 ms to + 180 mV, inserted prior to the test step34 (Fig. 2c). Activation curves were fit with a mod-
ified Boltzmann equation exhibiting a voltage-independent minimum open probability (Pmin) and a 
voltage-dependent term: P(V) = (Pmax − Pmin)/(1 + ezδF(V −V0.5)/RT) + Pmin, with zδ being the apparent gat-
ing charge, Pmax the maximum open probability and V0.5 the midpoint of activation. All values are given 
as mean ± SEM.
Noise analysis. Non-stationary noise-analysis was performed as previously described31. Currents 
were filtered at 10 kHz and digitized with a sampling rate of 50 kHz. A series of 50–300 sweeps was 
recorded upon voltage steps to − 155 mV and pairs of subsequent records were then subtracted using 
the Analysis software (kindly provided by Dr. F. Bezanilla, University of Chicago, USA) to compute 
non-stationary ensemble variances58. Current variances were corrected for the background variance 
measured at the reversal potential (− 5 mV) and sorted into evenly spaced current bins, with statistical 
errors superimposed as error bars.
hClC-1 channels exhibit a unique double-barreled architecture with two identical ion conduction 
pathways (protopores). For such channels with individual and common gating processes33,59 the current 
variance σ2 depends on the mean macroscopic current I, the number of active dimeric channels in the 
surface membrane N and the constant protopore current amplitude i, and also on the time-dependent 
open probabilities of protopore (Pp(t)) and common (Pc(t)) gates:
σ ( ) = ( ) ( )( − ( ) ( ) + ( )) ( )t N i Pp t Pc t Pp t Pc t Pp t2 1 2 92 2
The macroscopic current is represented by
( ) = ⋅ ( ) ( ) ( )I t N i Pp t Pc t2 10
Thus, equation (1) can be converted into
σ = ( + ( )) − ( )Pp t iI N
I1 1 11
2 2
The single protopore current amplitude i can therefore be calculated by dividing the slope of the 
variance-current plot at low current amplitudes by the sum of one and the minimum absolute open 
probability of the protopore gate (1+ Ppmin)33.
Simultaneous fluorescence and current recordings. For experiments correlating currents and 
the number of hClC-1-YFP fusion proteins, cells were cultivated on collagen coated glass cover slips 
and mounted in a perfusion chamber on an inverted IX71 microscope with UPlanSApo 60X/1.35 oil 
immersion objective (Olympus, Hamburg, Germany). mYFP was excited at 505 nm using a Polychrome 
V fast switching monochromator and emitted fluorescence light was detected at 530 nm using a PMT 
equipped ViewFinder III (Till Photonics, Gräfelfing, Germany)42,60. CFP was excited at 440 nm and 
detected at 470 nm. Fluorescence values were measured in the linear range of the photomultiplier and 
are given as arbitrary units (a.u.). Background fluorescence values and current amplitudes were measured 
on untransfected cells and found to be negligible. For multiple cells instantaneous current amplitudes 
at − 135 mV were plotted versus fluorescence values, and these relationships fitted with linear functions. 
The slope factor correlates with the fraction of membrane inserted channels and is therefore a valuable 
parameter to quantify the mean membrane insertion efficiency ± the standard error of the fit.
In experiments on cells co-expressing WT hClC-1-YFP and Q43R hClC-1-CFP relative fluorescence 
values for YFP and CFP were used to determine relative expression of WT and mutant subunits. To 
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account for different fluorescence amplitudes of individual mYFP or mCFP proteins, we determined 
the relative brightness factor (YFP/CFP = 3.0) of our experimental arrangement by comparing slopes of 
current-fluorescence plots for cells expressing WT hClC-1-YFP or WT hClC-1-CFP and corrected CFP 
fluorescence values by this factor.
Confocal imaging. Live cell confocal imaging was performed on transiently transfected MDCK II 
cells grown on special confocal tissue culture treated dishes (Ibidi, Martinsried, Germany). Confocal 
images were obtained using a Leica DM IRB confocal microscope with a TCS SP2 AOBS scan head (Leica 
Microsystems, Wetzlar, Germany) after 2 days expression of fluorescent YFP or CFP fusion proteins of 
WT or mutant hClC-1. Protein biosynthesis was interrupted 10–20 min before imaging by cycloheximide 
(0.04 mg/ml) to reduce the amount of immature hClC-1 proteins localized in intracellular compartments.
Biochemistry. To determine the expression levels of WT and mutant hClC-1-YFP fusion proteins 
(Fig.  1d) transfected HEK293T cells were lysed by incubation in 1% Triton X-100 in the presence of 
protease inhibitors (Sigma-Aldrich, Hamburg, Germany). After denaturation at room temperature in 
SDS sample buffer containing 100 mM dithiothreitol (DTT) cleared lysates were electrophoresed in par-
allel with fluorescent mass markers (Dual Color, Bio-Rad) on 10% SDS polyacrylamide gels. YFP-tagged 
proteins were visualized by scanning the wet PAGE gels with a fluorescence scanner (Typhoon, GE 
Healthcare, München, Germany), and individual bands were quantified with the ImageQuant software.
To account for potential differences in cell numbers, the total protein amount of each lysate was deter-
mined using the BCA Protein Assay (Thermo Scientific). For each gel, lysate samples were diluted to 
obtain identical total protein amounts in all lanes containing WT and mutant hClC-1.
We studied plasma membrane expression and oligomeric assembly of WT and mutant hClC-1 upon 
heterologous expression in Xenopus laevis oocytes. WT and Q43R hClC-1 were fused in frame by sequences 
encoding an amino-terminal hexahistidine tag and a carboxy-terminal StrepII-tag (NWSHPQFEK)61 or 
with sequences encoding mYFP and subcloned into pGEMHE61. Capped cRNA was synthesized through 
use of MESSAGE machine kits (Ambion, Austin, TX, USA), and collagenase-treated, defolliculated stage 
IV–V oocytes were microinjected with 10 ng of RNA (and incubated at 18 °C in ND96 (in mM: 96 NaCl, 
2 KCl, 1.8 CaCl2, 1 MgCl2, 5 Hepes, pH 7.6, supplemented with 2.5 sodium pyruvate and 50 μ g/ml gen-
tamycine sulfate). Proteins were metabolically labeled by incubating oocytes with 35S-methionine and 
cell surface-specific labeled using a membrane-impermeant Cy5-NHS ester. This system permits simple 
visual assessment of the intactness of individual oocytes using a stereo microscope and thus bypasses 
contamination of surface hClC-1 with intracellular channels labeled in leaky cells. hClC-1 channels were 
extracted by the mild non-ionic detergent digitonin as previously described46,63, purified via affinity 
chromatography using Ni-NTA-agarose (Qiagen, Hilden, Germany) and, in parallel, by Strep-TactinTM 
Sepharose (IBA, Göttingen, Germany) and resolved in the non-denatured state or SDS-denatured, 
dithiothreitol (DTT)-reduced state by blue native PAGE (BN-PAGE) and SDS-PAGE, as previously 
described38,50. PAGE gels were scanned first by a Typhoon fluorescence scanner and consecutively with 
a Phosphorimager to visualize the proteins through their fluorescence and incorporated 35S-methionine, 
respectively. Figures with images of PAGE gels were prepared with Image-Quant TL software version 7.0 
(GE Healthcare Biosciences) for contrast adjustments, Adobe Photoshop CS2 for level adjustment, spot 
(dust/hot pixel) removal and cropping and Microsoft PowerPoint for labeling.
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